MyFinsight
Home
Blog
About
Contact
Download
Download image
Net comprehensive
loss
-$190,528,000
Net unrealized gain
on...
$358,000
Net loss
-$190,886,000
Interest and other
income, net
$19,289,000
Other income
(expense), net
$215,000
Loss before income
taxes
-$190,886,000
Total other income
(expense), net
$18,429,000
Interest expense
$1,075,000
Loss from operations
-$209,315,000
Total operating
expenses
$209,315,000
Research and development
$150,152,000
General and
administrative
$56,781,000
Impairment of long-lived
asset
$2,382,000
Back
Back
Income Statement
source: myfinsight.com
Allogene Therapeutics, Inc. (ALLO)
Allogene Therapeutics, Inc. (ALLO)